Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at firstname.lastname@example.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
This comprehensive resource covers product change evaluation, postmarket surveillance, audit/inspection compliance, and various other laws and regulations pertaining to maintaining a product on the market.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
RAPS' Latest | 23 June 2016 | By Zachary Brousseau
One of the big draws of attending RAPS’ annual Regulatory Convergence is the opportunity to hear directly from regulators. Each year, the Convergence features dozens of speakers and panelists representing global regulatory agencies, including the US Food and Drug Administration (FDA), the European Medicines Agency (EMA), the China Food and Drug Administration and many others.
Among the highlights of last year’s Convergence in Baltimore was the opportunity to hear a keynote address from then-Acting FDA Commissioner Stephen Ostroff.
Ostroff began his remarks by calling the Regulatory Convergence the “perfect venue” for him to speak. “I feel like I’m speaking to my people,” he said. During the course of his presentation, he commented on ongoing changes at the agency, the “uncharted territory” of pending major regulatory legislation and user fee negotiations going on in the midst of a presidential election cycle, and he defended the agency against criticism that it stifles innovation. He also quoted Yogi Berra and Albert Einstein, and was well-received by attendees. You can view his full speech below or on YouTube.
To find out more about the speakers and agenda for this year’s Convergence in San Jose, CA, 17–20 September, visit RAPS.org/Convergence.
Tags: Regulatory Convergence, 2015, FDA, Ostroff, FDA Commissioner